RxDoctor Payments Data

Emily Wall, PA

Physician Assistant · Cheraw, SCNPI 1497523609

Payments from drug & device makers

$3,464in general payments, 2019–2025

Across 192 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$578
  • Novo Nordisk$389
  • Pfizer$260
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$250
  • AstraZeneca$246
  • Bayer$210
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$3,464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,464 in reported general payments places this provider in the 85th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$44,101
Medicare patients
229
Services billed
1,321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$34,856
JardianceEmpagliflozin18$19,706
MounjaroTirzepatide17$17,955
FarxigaDapagliflozin Propanediol14$15,941
EliquisApixaban19$13,399
TrulicityDulaglutide11$13,078
JanuviaSitagliptin Phosphate12$6,919
MyrbetriqMirabegron12$5,760
SymbicortBudesonide/Formoterol Fumarate12$4,276
Ezetimibe21$1,852
Albuterol Sulfate HfaAlbuterol Sulfate44$963
Omeprazole71$821
Atorvastatin Calcium85$768
Oxybutynin Chloride ErOxybutynin Chloride16$723
Gabapentin57$705

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$389$34,85634 claims
Lilly USA, LLCMounjaro, Trulicity$170$31,03328 claims
AstraZenecaFarxiga, Symbicort$246$20,21626 claims
Boehringer IngelheimJardiance$138$19,70618 claims
PfizerEliquis$260$13,39919 claims
MerckJanuvia$191$6,91912 claims
Astellas Pharma US IncMyrbetriq$21$5,76012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Cheraw

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →